New York State Common Retirement Fund Neurocrine Biosciences Inc Transaction History

New York State Common Retirement Fund

  • $74.6 Billion
  • Q4 2024

A detailed history of New York State Common Retirement Fund transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 177,774 shares of NBIX stock, worth $21.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
177,774
Previous 179,774 1.11%
Holding current value
$21.5 Million
Previous $20.7 Million 17.15%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$111.62 - $139.44 $223,240 - $278,880
-2,000 Reduced 1.11%
177,774 $24.3 Million
Q3 2024

Oct 28, 2024
SELL
$114.58 - $153.15 $3.28 Million - $4.39 Million
-28,633 Reduced 13.74%
179,774 $20.7 Million
Q2 2024

Jul 31, 2024
BUY
$130.86 - $143.19 $266,823 - $291,964
2,039 Added 0.99%
208,407 $28.7 Million
Q1 2024

May 07, 2024
SELL
$130.4 - $143.74 $1.05 Million - $1.15 Million
-8,028 Reduced 3.74%
206,368 $28.5 Million
Q4 2023

Feb 01, 2024
SELL
$106.07 - $132.76 $3.12 Million - $3.91 Million
-29,456 Reduced 12.08%
214,396 $28.2 Million
Q3 2023

Nov 07, 2023
BUY
$94.02 - $117.1 $2.87 Million - $3.58 Million
30,539 Added 14.32%
243,852 $27.4 Million
Q2 2023

Aug 07, 2023
BUY
$89.53 - $104.87 $791,803 - $927,470
8,844 Added 4.33%
213,313 $20.1 Million
Q1 2023

May 02, 2023
SELL
$94.11 - $123.02 $2.43 Million - $3.17 Million
-25,770 Reduced 11.19%
204,469 $20.7 Million
Q4 2022

Jan 30, 2023
SELL
$106.72 - $127.06 $4.67 Million - $5.56 Million
-43,761 Reduced 15.97%
230,239 $27.5 Million
Q3 2022

Nov 08, 2022
BUY
$92.03 - $107.81 $2.14 Million - $2.5 Million
23,213 Added 9.26%
274,000 $29.1 Million
Q2 2022

Aug 04, 2022
BUY
$75.79 - $100.07 $473,763 - $625,537
6,251 Added 2.56%
250,787 $24.4 Million
Q1 2022

May 05, 2022
BUY
$72.45 - $94.81 $2.28 Million - $2.98 Million
31,479 Added 14.77%
244,536 $22.9 Million
Q4 2021

Feb 02, 2022
BUY
$79.65 - $106.22 $157,468 - $209,996
1,977 Added 0.94%
213,057 $18.1 Million
Q3 2021

Nov 02, 2021
SELL
$86.18 - $99.03 $3.4 Million - $3.91 Million
-39,506 Reduced 15.77%
211,080 $20.2 Million
Q2 2021

Aug 02, 2021
SELL
$89.43 - $102.27 $215,615 - $246,572
-2,411 Reduced 0.95%
250,586 $24.4 Million
Q1 2021

May 11, 2021
SELL
$87.57 - $119.4 $902,759 - $1.23 Million
-10,309 Reduced 3.92%
252,997 $24.6 Million
Q4 2020

Feb 08, 2021
BUY
$86.91 - $108.33 $3.31 Million - $4.12 Million
38,035 Added 16.88%
263,306 $25.2 Million
Q3 2020

Nov 05, 2020
BUY
$96.16 - $135.15 $4.19 Million - $5.89 Million
43,563 Added 23.97%
225,271 $21.7 Million
Q2 2020

Aug 07, 2020
SELL
$85.09 - $130.36 $815,757 - $1.25 Million
-9,587 Reduced 5.01%
181,708 $22.2 Million
Q1 2020

May 06, 2020
SELL
$75.11 - $113.76 $56,708 - $85,888
-755 Reduced 0.39%
191,295 $16.6 Million
Q4 2019

Feb 05, 2020
SELL
$86.8 - $118.57 $5.33 Million - $7.29 Million
-61,447 Reduced 24.24%
192,050 $20.6 Million
Q3 2019

Nov 07, 2019
BUY
$83.82 - $101.5 $108,127 - $130,935
1,290 Added 0.51%
253,497 $22.8 Million
Q2 2019

Aug 09, 2019
BUY
$72.24 - $91.27 $593,957 - $750,421
8,222 Added 3.37%
252,207 $21.3 Million
Q1 2019

May 08, 2019
SELL
$69.31 - $91.53 $1.24 Million - $1.64 Million
-17,929 Reduced 6.85%
243,985 $21.5 Million
Q4 2018

Feb 08, 2019
SELL
$68.32 - $124.36 $876,545 - $1.6 Million
-12,830 Reduced 4.67%
261,914 $18.7 Million
Q3 2018

Nov 07, 2018
SELL
$98.88 - $125.85 $5,438 - $6,921
-55 Reduced 0.02%
274,744 $33.8 Million
Q2 2018

Aug 10, 2018
SELL
$75.3 - $105.99 $1.37 Million - $1.93 Million
-18,175 Reduced 6.2%
274,799 $27 Million
Q1 2018

May 10, 2018
SELL
$75.88 - $92.43 $76,638 - $93,354
-1,010 Reduced 0.34%
292,974 $24.3 Million
Q4 2017

Feb 13, 2018
BUY
$58.53 - $77.59 $1.97 Million - $2.61 Million
33,688 Added 12.94%
293,984 $22.8 Million
Q3 2017

Nov 06, 2017
BUY
$47.97 - $61.28 $234,813 - $299,965
4,895 Added 1.92%
260,296 $16 Million
Q2 2017

Aug 11, 2017
BUY
N/A
255,401
255,401 $11.7 Million

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.5B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email